Results 11 to 20 of about 850,964 (168)

“But the reality is it's happening”: A qualitative study of eating disorder providers about psilocybin‐assisted psychotherapy [PDF]

International Journal of Eating Disorders, 2023
AbstractObjectiveThis study invited providers who care for patients with eating disorders to inform engagement, communication, and collaboration with psilocybin‐assisted psychotherapy interventions.MethodMedical and mental health providers who treat patients with eating disorders were recruited via professional referral networks and participant driven ...
Amanda E. Downey, Maxine Boyd, Anita V. Chaphekar, Joshua Woolley, Marissa Raymond‐Flesch   +4 more
europepmc   +5 more sources

Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report [PDF]

Journal of Parkinson’s Disease
Background Psychedelic assisted psychotherapy (PAP) can improve treatment-resistant depression. Its usefulness in Parkinson's disease (PD) is unknown. PD patients may have problems adjusting to their chronic progressive neurological disease.
Vanessa Fleury, Emilie Tomkova, Sabina Catalano Chiuvé, Louise Penzenstadler   +3 more
doaj   +5 more sources

Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression [PDF]

Journal of Psychopharmacology
Background: Psilocybin-assisted psychotherapy (PAP) is a promising treatment for various psychiatric disorders. However, the exact biological and psychological mechanisms of action of PAP remain to be determined.
Joshua Rosenblat, Roger McIntyre, Rickinder Sethi   +2 more
exaly   +4 more sources

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +4 more sources

Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence [PDF]

Trends in Psychiatry and Psychotherapy
Eating disorders (ED) are a group of potentially severe mental disorders characterized by abnormal energy balance, cognitive dysfunction, and emotional distress.
Elena Koning, Elisa Brietzke
doaj   +4 more sources

Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder [PDF]

Frontiers in Pharmacology, 2018
After a hiatus of some 40 years, clinical research has resumed on the use of classic hallucinogens to treat addiction. Following completion of a small open-label feasibility study, we are currently conducting a double-blind placebo-controlled clinical trial of psilocybin-assisted treatment of alcohol use disorder.
Michael Bogenschütz, Sarah E Mennenga
exaly   +5 more sources

Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report

Psychoactives
Psychedelic substances have experienced a resurgence of clinical interest in recent years, particularly for their promising effects in the treatment of psychiatric disorders such as depression and anxiety.
Mathilda Mercier, Cedric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia-Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler   +9 more
doaj   +4 more sources

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.

JAMA Psychiatry, 2022
Importance: Although classic psychedelic medications have shown promise in the treatment of alcohol use disorder (AUD), the efficacy of psilocybin remains unknown. Question: Does psilocybin-assisted treatment improve drinking outcomes in patients with
Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O'Donnell K, Owens LT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L.   +12 more
europepmc   +2 more sources

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder [PDF]

Psychedelic Medicine
Background: Bipolar II disorder (BD-II) is often associated with chronic and treatment resistant major depressive episodes. Psilocybin has shown promise for its rapid-acting antidepressant effects, though its impact on bipolar depression remains unexplored.
Shakila Meshkat, Erica Kaczmarek, Zoe Doyle, Ryan M. Brudner, Fabiano A. Gomes, Marc G. Blainey, Geneva Weiglein, Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat   +9 more
openaire   +3 more sources

Psilocybin-assisted psychotherapy for treatment-resistant obsessive–compulsive disorder: protocol for an open-label pilot study [PDF]

BJPsych Open
Background Obsessive–compulsive disorder (OCD) is a debilitating mental disorder commonly treated with selective serotonin reuptake inhibitors, atypical antipsychotic augmentation and cognitive–behavioural therapy. However, up to 60% of people with OCD
Nicole Ledwos, Jenna Baer, Muhammad Ishrat Husain, Daniel M. Blumberger, Rachel Patterson, Elizabeth Hollingdrake, Ezmond Cheung, Colin Hawco, Christoph Zrenner, Brigitte Zrenner, Jamie D. Feusner, Susan L. Rossell, David J. Castle, Gwyneth Zai   +13 more
doaj   +2 more sources